New Drug Delivery Systems Concept in Anaesthesia and Intensive Care—Controlled Release of Active Compounds

Open access

Abstract

With time, medical and pharmaceutical research has advanced significantly. However, one of the major issues is how to administer the active substance. Among these, it counts over-or under-dosage of the active substance, low response to treatment, or increased clinical risk of the patient. An innovative method able to avoid these obstacles is represented by controlled release systems for active substances. The interest for these systems came with allowing encapsulation in the antibiotic release matrices, local anesthetics, protein or other substances. Moreover, a number of such vehicles are now available to release controlled substances used predominantly in the anesthesia and intensive care unit.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. Zhang Y Chan HF Leong KW. Advanced materials and processing for drug delivery: the past and the future. Adv Drug Deliv Rev 2013; 65:104-120

  • 2. Mrsny RJ. Oral drug delivery research in Europe. J Control Release 2012; 161:247-253

  • 3. Webster DM Sundaram P Byrne ME. Injectable nanomaterials for drug delivery: carriers targeting moieties and therapeutics. Eur J Pharm Biopharm 2013; 84:1-20

  • 4. Ukmar T Maver U Planinšek O Kaučič V Gaberšček M Godec A. Understanding controlled drug release from mesoporous silicates: Theory and experiment. Journal of Controlled Release 2011; 155:409-417

  • 5. Rana S Bajaj A Mout R Rotello VM. Monolayer coated gold nanoparticles for delivery applications. Adv Drug Deliv Rev 2012; 64:200-216

  • 6. Castro E Mosquera V Katime I. Dual Drug Release of Triamterene and Aminophylline from Poly(N-isopropylacrylamide) Hydrogels. Nanomater Nanotechnol 2012; 2:1-9

  • 7. Robeiro LN Alcântara AC Darder M Aranda P Araújo-Moreira FM Ruiz-Hitzky E. Pectin-coated chitosan-LDH bionanocomposite beads as potential systems for colon-targeted drug delivery. Int J Pharm 2014; 463:1-9

  • 8. Wang C Ye W Zheng Y Liu X Tong Z. Fabrication of drug-loaded biodegradable microcapsules for controlled release by combination of solvent evaporation and layer-by-layer self-assembly. Int J Pharm 2007; 338:165-173

  • 9. Ma J Zhang M Lu L Yin X Chen J Jiang Z. Intensifying esterification reaction between lactic acid and ethanol by pervaporation dehydration using chitosan-TEOS hybrid membranes. Chem Engin J 2009; 155:800-809

  • 10. Morpurgo M Teoli D Pignatto M Attrezzi M Spadaro F Realdon N. The effect of Na2CO3 NaF and NH4OH on the stability and release behavior of sol-gel derived silica xerogels embedded with bioactive compunds. Acta Biomater 2010; 6:2246-2253

  • 11. Estella J Echeverría JC Laguna M Garrido JJ. Effects of aging and drying conditions on the structural and textural properties of silica gels. Micropor Mesopor Mater 2007; 102:274-282

  • 12. Tsai CH Lin HJ Tsai HM Hwang JT Chang SM Chen-Yang YW. Characterization and PEMFC application of a mesoporous sulfonated silica prepared from two precursors tetraethoxysilane and phenyltriethoxysilane. Int J Hydrogen Energy 2011; 36:9831-9841

  • 13. Estella J Echeverría JC Laguna M Garrido JJ. Silica xerogels of tailored porosity as support matrix for optical chemical sensors. Simultaneous effect of pH ethanol:TEOS and water:TEOS molar ratios and synthesis temperature on gelation time and textural and structural properties. J NonCryst Solids 2007; 353: 286-294

  • 14. Timin AS Rumyantsev EV. Sol-gel synthesis of mesoporous silicas containing albumin and guanidine polymers and its application to the bilirubin adsorption. J Sol-Gel Sci Technol 2013; 67:297-303

  • 15. Radin S Chen T Ducheyne P. The controlled release of drugs from emulsified solgel processed silica microspheres. Biomaterials 2009; 30: 850-858

  • 16. Dudás Z Chiriac A Preda G. Simple entrapment of alcalase in different silica xerogels using the two steps sol-gel method. Annals of West University of Timişoara – Series Chemistry 2011; 20:97-104

  • 17. Tan S Wu Q Wang J et al. Dynamic self-assembly synthesis and controlled release as drug vehicles of porous hollow silica nanoparticles. Micropor Mesopor Mater 2011; 142:601-608

  • 18. Wang Y Grayson SM. Approaches for the preparation of non-linear amphiphilic polymers and their applications to drug delivery. Adv Drug Deliv Rev 2012; 64:852-865

  • 19. Prow TW Grice JE Lin LL et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 2011; 63: 470-491

  • 20. Jansen JFGA Meijer EW de Brabandervan den Berg EMM. The dendritic box: shape-selective liberation of encapsulated guests. J Am Chem Soc 1995; 117:4417-4418

  • 21. Venkataraman S Hedrick JL Ong ZY et al. The effects of polymeric nanostructure shape on drug delivery. Adv Drug Deliv Rev 2011; 63:1228-1246

  • 22. Mudshinge SR Deore AB Patil S Bhalgat CM. Nanoparticles: Emerging carriers for drug delivery. Saudi Pharm J 2011; 19:129-141

  • 23. Prakash S Malhotra M Shao W Tomaro-Duchesneau C Abbasi S. Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy. Adv Drug Deliv Rev 2011; 63:1340-1351

  • 24. Han G Ghosh P De M Rotello VM. Drug and gene delivery using gold nanoparticles. Nanobiotechnol 2007; 3:40-45

  • 25. Janib SM Moses AS MacKay JA. Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev 2010; 62:1052-1063

  • 26. Lee KY Yuk SH. Polymeric protein delivery systems. Prog Polym Sci 2007; 32:669-697

  • 27. Suh WH Suslick KS Stucky GD Suh YH. Nanotechnology nanotoxicology and neuroscience. Prog Neurobiol 2009; 87:133-170

  • 28. Portney NG Ozkan M. Nano-oncology: drug delivery imaging and sensing. Anal Bioanal Chem 2006; 384:620-630

  • 29. Zalfen AM Nizet D Jérôme C et al. Controlled release of drugs from multicomponent biomaterials. Acta Biomater 2008; 4:1788-1796

  • 30. Cheng S Song Q Wei D Gao B. High-level production penicillin G acylase from Alcaligenes faecalis in recombinant Escherichia coli with optimization of carbon sources. Enzyme Microb Technol 2007; 41:326-330

  • 31. Wang F Saidel GM Gao J. A mechanistic model of controlled drug release from polymer millirods: effects of excipients and complex binding. Control Release 2007; 119:111-120

  • 32. Machín R Isasi JR Vélaz I. Hydrogel matrices containing single and mixed natural cyclodextrins. Mechanisms of drug release. Eur Polym J 2013; 49: 3912-3920

  • 33. Kona S Dong JF Liu Y Tan J Nguyen KT. Biodegradable nanoparticles mimicking platelet binding as a targeted and controlled drug delivery system. Int J Pharm 2012; 423:516-524

  • 34. Krishnamachari Y Geary SM Lemke CD Salem AK. Nanoparticle delivery systems in cancer vaccines. Pharm Res 2011; 28:215-236

  • 35. Xia W Chang J Lin J Zhu J. The pH-controlled dual-drug release from mesoporous bioactive glass/polypeptide graft copolymer nanomicelle composites. Eur J Pharm Biopharm 2008; 69:546-552

  • 36. Kreye F Siepmann F Siepmann J. Drug release mechanisms of compressed lipid implants. Int J Pharm 2011; 404:27-35

  • 37. Tran PHL Choe JS Tran TTD Park YM Lee BJ. Design and mechanism of onoff pulsed drug release using nonenteric polymeric systems via pH modulation. AAPS PharmSciTech 2011; 12:46-55

  • 38. Hayashi T Kanbe H Okada M et al. Formulation study and drug release mechanism of a new theophylline sustained-release preparation. Int J Pharm 2005; 304: 91-101

  • 39. Yoshida T Tasaky H Maeda A Katsuma M Sako K Uchida T. Mechanism of controlled drug release from a salting-out taste-masking system. J Control Release 2008; 131:47-53

  • 40. Fredenberg S Wahlgren M Reslow M Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems – A review. Int J Pharm 2011; 415:34-52

  • 41. Ferrero C Massuelle D Doelker E. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis. J Control Release 2010; 141: 223-233

  • 42. Gustavsson A Bjorkman J Ljungcrantz C et al. Pharmaceutical treatment patterns for patients with a diagnosis related to chronic pain initiating slow-release strong opioid treatment in Sweden. Pain 2012; 153:2325-2331

  • 43. Hoya Y Okamoto T Yanaga K. Evaluation of analgesic effect and safety of fentanyl transdermal patch for cancer pain as the first line. Support Care Cancer 2010; 18:761-764

  • 44. Kress HG Von der Laage D Hoerauf KH et al. A randomized open parallel group multicenter trial to investigate analgesic efficacy and safety of a new transdermal fentanyl patch compared to standard opioid treatment in cancer pain. J Pain Symptom Manage 2008; 36: 268-279

  • 45. Lane ME. The Transdermal delivery of fentanyl. Eur J Pharm Biopharm 2013; 84:449-455

  • 46. Minkowitz HS. Fentanyl iontophoretic transdermal system: a review. Tech Reg Anesth Pain Managt 2007; 11: 3-8

  • 47. Freynhagen R von Giesen HJ Busche P Sabatowski R Konrad C Grond S. Switching from reservoir to matrix systems for the transdermal delivery of fentanyl: a prospective multicenter pilot study in outpatients with chronic pain. J Pain Symptom Manage 2005; 30:289-297

  • 48. Margetts L Sawyer R. Transdermal drug delivery: principles and opioid therapy. Contin Educ Anaesth Crit Care Pain 2007; 7:171-176

  • 49. Kress HG Boss H Delvin T et al. Transdermal fentanyl matrix patches Matrifen and Durogesic DTrans are bioequivalent. Eur J Pharm Biopharm 2010; 75:225-231

  • 50. Bajaj S Whiteman A Brandner B. Transdermal drug delivery in pain management. Contin Educ Anaesth Crit Care Pain 2011; 11:39-43

  • 51. Coulthard P Oliver R Khan Afridi KA Jackson-Leech D Adamson L Worthington H. The efficacy of local anaesthetic for pain after iliac bone harvesting: a randomised controlled trial. Int J Surg 2008; 6:57-63

  • 52. Ilfeld BM Malhotra N Furnish TJ Donohue MC Madison SJ. Liposomal bupivacaine as a single-injection peripheral nerve block: a dose-response study. Anesth Analg 2013; 117:1248-1256

  • 53. Viscusi ER Candiotti KA Onel E Morren M Ludbrook GL. The pharmacokinetics and pharmacodynamics of liposome bupivacaine administered via a single epidural injection to healthy volunteers. Reg Anesth Pain Med 2012; 37:616-622

  • 54. Tsuchiya H Ueno T Mizogami M Takakura K. Local anesthetics structure-dependently interact with anionic phospholipid membranes to modify the fluidity. Chem Biol Interact 2010; 183:19-24

  • 55. Shikanov A Domb AJ Weiniger CF. Long acting local anesthetic-polymer formulation to prolong the effect of analgesia. J Control Release 2007; 117: 97-103

  • 56. Rodriguez-Navarro AJ Lagos M Figueroa C et al. Potentiation of local anesthetic activity of neosaxitoxin with bupivacaine or epinephrine: development of a long-acting pain blocker. Neurotox Res 2009; 16:408-415

Search
Journal information
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 115 115 22
PDF Downloads 71 71 8